Get the Stockscreener App
14.71
0.27%
-0.04
Pre-market:
14.98
0.27
+1.84%
Si Bone Inc stock is traded at $14.71, with a volume of 251.71K.
It is down -0.27% in the last 24 hours and down -10.30% over the past month.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$14.75
Open:
$14.7
24h Volume:
251.71K
Relative Volume:
0.73
Market Cap:
$624.49M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-14.56
EPS:
-1.01
Net Cash Flow:
$-25.98M
1W Performance:
-10.09%
1M Performance:
-10.30%
6M Performance:
-6.48%
1Y Performance:
-9.31%
1-Day Range:
$14.61
$15.30
1-Week Range:
$14.61
$16.78
52-Week Range:
$11.70
$19.16
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
14.71 | 624.49M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
Proficio Capital Partners LLC Takes Position in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia
(SIBN) Investment Analysis - Stock Traders Daily
SI-BONE’s SWOT analysis: stock poised for growth amid challenges - Investing.com India
SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Rhumbline Advisers - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by New York State Common Retirement Fund - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Receives $24.50 Average Target Price from Analysts - Defense World
VELA Investment Management LLC Boosts Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
SI-BONE (NASDAQ:SIBN) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
SI-BONE (NASDAQ:SIBN) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Truist Financial Reiterates "Buy" Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
SI-BONE (NASDAQ:SIBN) Hits New 1-Year High on Analyst Upgrade - MarketBeat
Cantor Fitzgerald Reiterates "Overweight" Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
SI-BONE FY2025 EPS Estimate Decreased by Cantor Fitzgerald - MarketBeat
SI-BONE (NASDAQ:SIBN) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
SI-BONE (NASDAQ:SIBN) Sets New 12-Month High Following Analyst Upgrade - Defense World
SI-BONE (NASDAQ:SIBN) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
SI-Bone price target raised to $24 from $20 at Needham - Yahoo Finance
Nikon Metrology Europe Appoints President: People in the News: 2/26/25 | Business | Feb 2025 - Photonics.com
SI-BONE (NASDAQ:SIBN) Shares Gap Up Following Earnings Beat - Defense World
Expert Outlook: SI-BONE Through The Eyes Of 5 Analysts - Benzinga
SI-BONE, Inc. (NASDAQ:SIBN) Q4 2024 Earnings Call Transcript - MSN
SI-Bone’s Strong Financial Performance and Promising Outlook Justifies Buy Rating and Raised Price Target - TipRanks
Cantor Fitzgerald maintains SI-BONE stock overweight with $25 target - Investing.com
Cantor Fitzgerald maintains SI-BONE stock overweight with $25 target By Investing.com - Investing.com South Africa
Earnings call transcript: Si-Bone Q4 2024 beats EPS forecast, stock rises - Investing.com Australia
SI-Bone price target raised to $22 from $18 at Truist - TipRanks
Needham raises SI-BONE stock target to $24 on strong guidance By Investing.com - Investing.com South Africa
Needham raises SI-BONE stock target to $24 on strong guidance - Investing.com India
SI-BONE worldwide revenue increases 26% to USD 49M in Q4 2024 - Medical Buyer
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates - MSN
SI-BONE Inc (SIBN) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Positive EBITDA - Yahoo Finance
SI-Bone: Strong Financial Performance and Strategic Positioning Justify Buy Rating - TipRanks
Si-Bone: Q4 Earnings Snapshot - Huron Daily Tribune
SI-BONE, Inc. Reports Record Growth and Positive EBITDA - TipRanks
Si-Bone earnings beat by $0.04, revenue topped estimates - Investing.com Canada
SI-BONE Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Si-Bone: Q4 Earnings Snapshot -February 24, 2025 at 04:44 pm EST - Marketscreener.com
SI-BONE Inc. Q4 Loss Declines - Nasdaq
SI-Bone reports Q4 EPS (11c), consensus (13c) - TipRanks
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance - The Manila Times
EverCommerce Announces Date of Fourth Quarter 2024 Earnings Call - The Manila Times
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results, Achieving Significant Revenue Growth and Positive Adjusted EBITDA - Nasdaq
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):